Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,285 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study.
Tiede A, Hart C, Knöbl P, Greil R, Oldenburg J, Sachs UJ, Miesbach W, Pfrepper C, Trautmann-Grill K, Holstein K, Pilch J, Möhnle P, Schindler C, Weigt C, Schipp D, May M, Dobbelstein C, Pelzer FJ, Werwitzke S, Klamroth R. Tiede A, et al. Among authors: hart c. Lancet Haematol. 2023 Nov;10(11):e913-e921. doi: 10.1016/S2352-3026(23)00280-6. Epub 2023 Oct 16. Lancet Haematol. 2023. PMID: 37858328 Clinical Trial.
Detection and quantification of functionally defined hematopoietic progenitor cells and tissue specific mRNA within the peripheral blood of myeloma patients after administration of granulocyte colony-stimulating factor and erythropoietin.
Grassinger J, Mueller G, Hart C, Nilsson SK, Haylock DN, Andreesen R, Hennemann B. Grassinger J, et al. Among authors: hart c. Eur J Haematol. 2008 Jan;80(1):20-30. doi: 10.1111/j.1600-0609.2007.00983.x. Epub 2007 Nov 19. Eur J Haematol. 2008. PMID: 18028434 Clinical Trial.
Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial.
Einsele H, Engelhardt M, Tapprich C, Müller J, Liebisch P, Langer C, Kropff M, Mügge LO, Jung W, Wolf HH, Metzner B, Hart C, Gramatzki M, Hertenstein B, Pfreundschuh M, Rösler W, Fischer T, Maschmeyer G, Kanz L, Hess G, Jäger E, Bentz M, Dürk HA, Salwender H, Hebart H, Straka C, Knop S. Einsele H, et al. Among authors: hart c. Br J Haematol. 2017 Nov;179(4):586-597. doi: 10.1111/bjh.14920. Epub 2017 Sep 29. Br J Haematol. 2017. PMID: 28961309 Free article. Clinical Trial.
Laboratory Diagnostics in Thrombophilia.
Linnemann B, Hart C. Linnemann B, et al. Among authors: hart c. Hamostaseologie. 2019 Feb;39(1):49-61. doi: 10.1055/s-0039-1677840. Epub 2019 Jan 31. Hamostaseologie. 2019. PMID: 30703819 Review.
Primary Thromboprophylaxis in Patients with Malignancies: Daily Practice Recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO), the Society of Thrombosis and Hemostasis Research (GTH), and the Austrian Society of Hematology and Oncology (ÖGHO).
Kirschner M, do Ó Hartmann N, Parmentier S, Hart C, Henze L, Bisping G, Griesshammer M, Langer F, Pabinger-Fasching I, Matzdorff A, Riess H, Koschmieder S. Kirschner M, et al. Among authors: hart c. Cancers (Basel). 2021 Jun 10;13(12):2905. doi: 10.3390/cancers13122905. Cancers (Basel). 2021. PMID: 34200741 Free PMC article. Review.
Women's Health Issues in Thrombosis and Haemostasis.
Linnemann B, Hart C; Speakers of the GTH Working Group "Women's Health". Linnemann B, et al. Among authors: hart c. Hamostaseologie. 2022 Oct;42(5):285-286. doi: 10.1055/s-0042-1757549. Epub 2022 Nov 7. Hamostaseologie. 2022. PMID: 36343647 Free article.
2,285 results